Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Statins -

Statins

Indications & Uses, Safety & Modes of Action

Gunnar N Holmqvist (Herausgeber)

Buch | Hardcover
205 Seiten
2009
Nova Science Publishers Inc (Verlag)
978-1-60692-103-6 (ISBN)
CHF 247,65 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
A high cholesterol level increases a person's risk of having a heart attack or stroke. The long-term use of statins reduces the risk of such an event and can increase the life expectancy of people with a history of heart disease. This book focuses on statins which are a group of drugs used to lower blood cholesterol levels.
This book focuses on statins which are a relatively new group of drugs used to lower blood cholesterol levels. A high cholesterol level increases a person's risk of having a heart attack or stroke. The long-term use of statins reduces the risk of such an event and can increase the life expectancy of people with a history of heart disease. The statins work by blocking an enzyme in the body that is involved in the production of LDL cholesterol, especially in the liver. This enzyme is known as HMG coenzyme A reductase. The statins are the most effective group of drugs for lowering the levels of LDL cholesterol in the body. Potential side-effects include muscle cramps and gastrointestinal upsets. These are usually resolved on temporarily lowering the dose. Liver enzyme derangements may occur, which generally return to normal after briefly discontinuing the drug. Some report headaches. Other side-effects occur rarely.

Preface; Statin Therapy for Coronary Artery Disease Beyond Lipid Lowering Effect; Side Effects of Statins In Monotherapy; Preliminary findings about the trends of the renal hemodynamics and the proxies of cardiovascular risk during a short course of atorvastatin therapy in essential hypertensives; Beneficial effects of addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions; Non-lipid lowering effects of statins; Statins in the Therapy of Acute Coronary Syndrome;; Beneficial Effects of Addition of Fenofibrate to Statin Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Interventions; Bad HDL-C Responders to Statins; Beneficial Effects of Addition of Fenofibrate to Statin Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Interventions; Beneficial Effects of Statins in Systemic Lupus Erythematosus: Molecular Mechanism Involved; Index.

Erscheint lt. Verlag 1.7.2009
Zusatzinfo Illustrations
Verlagsort New York
Sprache englisch
Maße 260 x 180 mm
Gewicht 614 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 1-60692-103-7 / 1606921037
ISBN-13 978-1-60692-103-6 / 9781606921036
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich